Liquid biopsy in BALF is now suitable for clinical practice in patients with suspected NSCLC.
- DOI
- 10.1016/j.lungcan.2025.108771
- Published
- 2025 Nov
- Container
- Lung cancer (Amsterdam, Netherlands)
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.lungcan.2025.108771,
title = {Liquid biopsy in BALF is now suitable for clinical practice in patients with suspected NSCLC.},
author = {Borm FJ and Schelhaas MJ and Steeghs EMP and Timmer CW and Wijngaarden KRV and Egmond DV and Smit J and Eijk RV and Wezel TV and Smit EF and Cohen D},
year = {2025},
journal = {Lung cancer (Amsterdam, Netherlands)},
doi = {10.1016/j.lungcan.2025.108771},
url = {https://doi.org/10.1016/j.lungcan.2025.108771}
}RIS
TY - JOUR TI - Liquid biopsy in BALF is now suitable for clinical practice in patients with suspected NSCLC. AU - Borm FJ AU - Schelhaas MJ AU - Steeghs EMP AU - Timmer CW AU - Wijngaarden KRV AU - Egmond DV AU - Smit J AU - Eijk RV AU - Wezel TV AU - Smit EF AU - Cohen D PY - 2025 JO - Lung cancer (Amsterdam, Netherlands) DO - 10.1016/j.lungcan.2025.108771 UR - https://doi.org/10.1016/j.lungcan.2025.108771 ER -
APA
FJ, B., MJ, S., EMP, S., CW, T., KRV, W., DV, E., J, S., RV, E., TV, W., EF, S., & D, C. (2025). Liquid biopsy in BALF is now suitable for clinical practice in patients with suspected NSCLC.. Lung cancer (Amsterdam, Netherlands). https://doi.org/10.1016/j.lungcan.2025.108771
Source records
- pubmed · retrieved 2026-09-27T01:31:34.317Z
- europe-pmc · retrieved 2026-09-27T01:31:34.334Z